Henry Gosebruch, Neumora CEO
Neumora goes big with three PhIII depression studies, new CEO from AbbVie’s C-suite
The wheels are rolling fast at Neumora as the “Really Big Neuroscience Company” nears three Phase III trials for its investigational depression drug, readies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.